Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-20-000025

Director sold 15,786 shares at $58.96 ($930,714)

  • Director acquired 15,786 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SULLIVAN LOUIS W · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-04 Exercise or conversion : show line 1 in the form +7,893 $13.00 $102,609 68,359 D
2020-03-04 Sale : show line 2 in the form −7,893 $58.96 $465,357 60,466 D
2020-03-04 Exercise or conversion : show line 3 in the form +7,893 $14.71 $116,106 68,359 D
2020-03-04 Sale : show line 4 in the form −7,893 $58.96 $465,357 60,466 D
Open-market sales · 15,786 sh · avg $58.96 · $930,714

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-04 Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) −7,893 $14.71 $116,106 0 D
2020-03-04 Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) −7,893 $13.00 $102,609 0 D
Loading xslF345X03/wf-form4_158353064805074.xml…